Itraconazole is a prescription antifungal medication used to treat a range of fungal infections, from serious lung and body-wide infections to stubborn nail fungus. It works by disrupting the cell membranes of fungi, stopping them from growing and spreading. It’s available as capsules and an oral solution, and treatment can last anywhere from a couple of weeks to over a year depending on the infection.
Serious Fungal Lung and Body Infections
Itraconazole is approved to treat three systemic (body-wide) fungal infections: blastomycosis, histoplasmosis, and aspergillosis. These are caused by fungi that typically enter the body through the lungs when you breathe in spores, and they can spread to other organs in severe cases. People with weakened immune systems are especially vulnerable, but healthy individuals can develop these infections too.
Blastomycosis and histoplasmosis are endemic to certain regions of the United States, particularly the Ohio and Mississippi River valleys and the Great Lakes area. For mild to moderate cases, itraconazole is often the primary treatment. For histoplasmosis specifically, mild cases that linger beyond a month are typically treated with itraconazole for 6 to 12 weeks. Chronic cavitary pulmonary histoplasmosis, a more persistent form, requires at least a year of treatment, and some specialists extend that to 18 to 24 months because of the risk of relapse. When histoplasmosis spreads beyond the lungs, treatment lasts at least 12 months.
For aspergillosis, itraconazole is specifically approved for patients who can’t tolerate or haven’t responded to another antifungal. It serves as a second-line option rather than a first choice for this particular infection.
Nail Fungus (Onychomycosis)
The other major use for itraconazole is treating fungal nail infections caused by dermatophytes, the group of fungi responsible for most nail fungus. This is one of the more common reasons it’s prescribed, since nail fungus affects millions of people and topical treatments often fail to penetrate the nail deeply enough.
For toenail fungus, the standard approach is taking itraconazole once daily for 12 consecutive weeks. Fingernail infections use a different strategy called pulse therapy: you take itraconazole twice daily for one week, stop for three weeks, then repeat for another one-week course. The idea behind pulse therapy is that the drug accumulates in nail tissue and continues working during the off weeks, reducing your overall exposure to the medication. Even after treatment ends, it takes months for the healthy nail to fully grow in and replace the damaged portion, so visual improvement is gradual.
How Formulation Affects Absorption
Itraconazole comes in three forms: conventional capsules, an oral solution, and a newer formulation sometimes called “super-bioavailability” or SUBA itraconazole. The differences between them matter more than you might expect.
Conventional capsules need stomach acid to dissolve properly, so they should be taken with a full meal to maximize absorption. Anything that reduces stomach acid, including common heartburn medications, can significantly lower how much drug your body actually absorbs. The absorption of conventional capsules also varies quite a bit from person to person and even from dose to dose in the same person.
The newer SUBA formulation was designed to solve these problems. It releases the drug in the small intestine instead of the stomach, improving bioavailability by about 173% compared to conventional capsules while cutting person-to-person variability by roughly 21%. Food and stomach acid levels have minimal impact on its absorption, with blood levels in the fed and fasted state staying within about 10% of each other. This makes dosing more predictable and reduces the chance of treatment failure from poor absorption. It’s worth knowing which formulation you’ve been prescribed, since the doses are not interchangeable.
Important Safety Concerns
Itraconazole carries an FDA boxed warning, the most serious type of safety alert, related to heart effects. The drug can weaken the heart’s pumping ability, a negative inotropic effect that was observed in both animal studies and human volunteers. People with a history of heart failure should generally not take itraconazole. If you develop shortness of breath, swelling in your legs, unusual fatigue, or other signs of heart problems while on the medication, treatment should be stopped.
Liver injury is the other significant risk. In clinical trials for systemic fungal infections, about 3% of patients developed abnormal liver function. Among patients treated for toenail fungus, 4% had liver enzyme elevations significant enough to require stopping the medication, either temporarily or permanently. Rare cases of serious liver failure, including deaths, have been reported. Your doctor will likely monitor your liver function with blood tests, particularly if you have any pre-existing liver issues or are taking other medications that stress the liver.
Itraconazole also interacts with a long list of other drugs. It blocks a key enzyme your body uses to break down many common medications, which can cause dangerous buildups of those drugs in your system. Always make sure your prescriber knows every medication and supplement you’re taking.
Use in Older Adults and Children
Itraconazole has not been formally established as safe and effective in children. Animal studies in young rats found bone abnormalities after prolonged use, and the long-term effects on bone growth in children are unknown. When it is used in pediatric patients for serious infections, dosing is weight-based and typically uses the oral solution rather than capsules.
For adults 65 and older, hearing loss has been reported, sometimes reversible and sometimes permanent. This risk appears to increase when itraconazole is combined with certain other medications. Older adults are also more likely to have reduced liver, kidney, or heart function, all of which can affect how the body handles the drug and may require more cautious dosing.